Clinical Trial Update: Embolization of the Middle Meningeal Artery for the Prevention of Chronic Subdural Hematoma Recurrence in High Risk Patients (EMPROTECT) [NA]

View source ↗

Summary

The EMPROTECT trial evaluating embolization of the middle meningeal artery to prevent recurrence of chronic subdural hematoma in high-risk patients has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Chronic Subdural Hematoma, At Risk of Post-operative Recurrence | NA | Status: COMPLETED